metformin has been researched along with gosogliptin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dai, H; Johnson, SL; Lewin, AJ; Nguyen, TT; Norwood, P; Rosenstock, J; Somayaji, V; Teeter, JG; Terra, SG | 1 |
Calle, RA; Dai, H; Lewin, AJ; Nguyen, TT; Schwartz, S; Somayaji, V; Teeter, JG; Terra, SG | 1 |
2 trial(s) available for metformin and gosogliptin
Article | Year |
---|---|
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Epidemiologic Methods; Female; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pyrimidines; Pyrrolidines; Treatment Outcome; Young Adult | 2011 |
A Dose-Ranging Study of the DPP-IV Inhibitor PF-734200 Added to Metformin in Subjects With Type 2 Diabetes*.
Topics: Adolescent; Adult; Aged; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Protease Inhibitors; Pyrimidines; Pyrrolidines | 2011 |